ATE169680T1 - 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper - Google Patents

6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper

Info

Publication number
ATE169680T1
ATE169680T1 AT94900935T AT94900935T ATE169680T1 AT E169680 T1 ATE169680 T1 AT E169680T1 AT 94900935 T AT94900935 T AT 94900935T AT 94900935 T AT94900935 T AT 94900935T AT E169680 T1 ATE169680 T1 AT E169680T1
Authority
AT
Austria
Prior art keywords
pct
mgmt
hybridoma ecacc
nov
date jun
Prior art date
Application number
AT94900935T
Other languages
English (en)
Inventor
Benjamin Fuk Loi Li
Teck Choon Ayi
Original Assignee
Inst Of Molecul & Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Molecul & Cell Biology filed Critical Inst Of Molecul & Cell Biology
Application granted granted Critical
Publication of ATE169680T1 publication Critical patent/ATE169680T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94900935T 1992-11-27 1993-11-29 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper ATE169680T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929224888A GB9224888D0 (en) 1992-11-27 1992-11-27 Monoclonal antibody

Publications (1)

Publication Number Publication Date
ATE169680T1 true ATE169680T1 (de) 1998-08-15

Family

ID=10725777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900935T ATE169680T1 (de) 1992-11-27 1993-11-29 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper

Country Status (10)

Country Link
US (1) US5817514A (de)
EP (1) EP0670908B1 (de)
AT (1) ATE169680T1 (de)
AU (1) AU688289B2 (de)
CA (1) CA2149867A1 (de)
DE (1) DE69320364T2 (de)
ES (1) ES2119992T3 (de)
GB (1) GB9224888D0 (de)
SG (1) SG48841A1 (de)
WO (1) WO1994012660A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase
JP2004509643A (ja) * 2000-09-29 2004-04-02 ザ　ジョンズ　ホプキンス　ユニバーシティー　スクール　オブ　メディシン アルキル化剤を用いた化学療法による治療に対する臨床反応を予測する方法
NZ537939A (en) * 2001-04-10 2005-08-26 Ecole Polytech Methods using O6-alkylguanine-DNA alkyltransferases for labelling a protein of interest which is fused to the AGT
EP1973569B1 (de) 2006-01-18 2013-05-22 Merck Patent GmbH Spezifische therapie mit integrin-liganden zur krebsbehandlung
JP2010516645A (ja) 2007-01-18 2010-05-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌を治療するためのインテグリンリガンドを用いる特異的療法および薬剤
EP2409700A1 (de) 2007-05-08 2012-01-25 Schering Corporation Verfahren zur Behandlung mit intravenösen Formulierungen mit Temozolomid
US20110159006A1 (en) * 2008-06-19 2011-06-30 Erik Hack Use of anti-factor xi antibodies for prevention of thrombus formation
US20120130146A1 (en) 2009-05-25 2012-05-24 Merck Patent Gmbh Continuous administration of cilengitide in cancer treatments
MX2013000521A (es) 2010-07-16 2013-03-05 Merck Patent Gmbh Partido para usarse en tratamiento de cancer de mama y/o metastasis osea.
WO2013076304A1 (en) * 2011-11-25 2013-05-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Monoclonal antibody for the detection of snap/clip tag
ES2648899T3 (es) 2011-12-09 2018-01-08 Institut Pasteur Inmunoensayo de cribado múltiplex

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase

Also Published As

Publication number Publication date
GB9224888D0 (en) 1993-01-13
ES2119992T3 (es) 1998-10-16
DE69320364T2 (de) 1998-12-10
EP0670908B1 (de) 1998-08-12
SG48841A1 (en) 1998-05-18
AU5570594A (en) 1994-06-22
US5817514A (en) 1998-10-06
EP0670908A1 (de) 1995-09-13
CA2149867A1 (en) 1994-06-09
WO1994012660A1 (en) 1994-06-09
DE69320364D1 (de) 1998-09-17
AU688289B2 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
Harada et al. Identification of early plasma cells in peripheral blood and their clinical significance
TR200002405T2 (tr) İnsan CD40' a karşı antikorlar
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
AU2001258567A1 (en) Humanised antibodies to the epidermal growth factor receptor
DE69840383D1 (de) Ctl epitope des epstein-barr virus
NZ508381A (en) Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5)
AU2555297A (en) Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
ATE212038T1 (de) Humanisierte monoklonale anti-cd40 antikörper und fragmente zur hemmung der b-zellaktivierung
ATE169680T1 (de) 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper
ATE208820T1 (de) Humanisierte antikoerper
SE9103183L (sv) Virus-antikroppskomplex
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
Thomas et al. Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous‐cell carcinoma
ATE174967T1 (de) Monoklonale antikörper gegen glykoprotein p
GR3029483T3 (en) Antibodies against t-cells as therapeutics
AU1971295A (en) Humanized monoclonal antibodies against human interleukin-4
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
ATE288485T1 (de) Monoklonaler antikörper 4g8b4b12 gegen humanes flt3/flk2
ATE276277T1 (de) Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
GB2284608A (en) 06-Methylguanine-DNA-methyltransferase (mgmt) specific antibodies
Leanderson et al. Effects of μ‐specific antibodies on B cell growth and maturation
ATE293685T1 (de) Monoklonaler antikörper gegen ratte beta-2- integrin alpha d untereinheit und entsprechendes hybridoma
ATE279729T1 (de) Beurteilung von cerrixzellen
ATE251643T1 (de) Antikörper 67d2 gegen cd164

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties